German ophthalmic device-maker Implandata Ophthalmic Products said it raised €3 million (about $3.8 million) in its latest funding round and established a Delaware-based subsidiary to help launch its lead product in the U.S.
Optical/Ophthalmic
FDA studies show nearly half of LASIK patients report problems
Abbott inks co-distribution deal with Carl Zeiss Meditec
Sinopsys Surgical sniffs up $8.3m for sinusitis device
Stealth-mode startup Sinopsys Surgical said it raised $8.3 million in an equity funding round for the technique it’s developing to repurpose the tear duct to drain into the sinuses as a way to relieve chronic sinusitis.
CEO Dr. Harry Ross was a partner with Aweida Venture Partners of Superior, Colo., near to Sinopsys Surgical’s Boulder headquarters.
MID Labs lands $51m for eye surgery devices
MID Labs Ltd. said today that it raised a $51 million funding round for its eye surgery devices it plans to use to expand in the U.S. and China.
The round, led by OrbiMed and Frontline BioVentures, also included Softbank China Venture Capital, Allen Chao and Sungent BioVenture, according to a press release.
Feds fight dismissal of charges in Abbott-AMO insider trading case
Ocular Therapeutix set to start 2 Phase III studies for eye-duct plug
Ex-Oriole DeCinces fights insider trading charges
Ex-Oriole DeCinces fights insider trading charges
Second Sight Medical eyes $3m bridge to IPO
Second Sight Medical is looking to bridge the gap to its forthcoming initial public offering with a $3 million loan from iconic chairman Al Mann.